Citations to this article

What should define a SARS-CoV-2 “breakthrough” infection?
John S. Schieffelin, … , Elizabeth B. Norton, Jay K. Kolls
John S. Schieffelin, … , Elizabeth B. Norton, Jay K. Kolls
Published May 11, 2021
Citation Information: J Clin Invest. 2021;131(12):e151186. https://doi.org/10.1172/JCI151186.
View: Text | PDF
Viewpoint Article has an altmetric score of 482

What should define a SARS-CoV-2 “breakthrough” infection?

Abstract

Authors

John S. Schieffelin, Elizabeth B. Norton, Jay K. Kolls

×

Total citations by year

Year: 2023 2022 2021 Total
Citations: 2 9 2 13
Citation information

Citations to this article (13)

Title and authors Publication Year
Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
Buscot M, Cremoni M, Graça D, Brglez V, Courjon J, Allouche J, Teisseyre M, Boyer L, Barrière J, Chamorey E, Carles M, Seitz-Polski B 		Frontiers in immunology 2023
Updated Considerations for the Immunopharmacological Aspects of the “Talented mRNA Vaccines”
Perrotta C, Fenizia C, Carnovale C, Pozzi M, Trabattoni D, Cervia D, Clementi E 		Human vaccines 2023
Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2
G Malipiero, P D'Agaro, L Segat, A Moratto, D Villalta 		Clinica chimica acta; international journal of clinical chemistry 2022
A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant
M Zhang, Y Liang, D Yu, B Du, W Cheng, L Li, Z Yu, S Luo, Y Zhang, H Wang, X Zhang, W Zhang 		International journal of biological sciences 2022
Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs
T Dzinamarira, N Tungwarara, I Chitungo, M Chimene, P Iradukunda, M Mashora, G Murewanhema, G Rwibasira, G Musuka 		Human vaccines 2022
Engineering monoclonal antibodies for COVID-19 prophylaxis
A Izadpanah, J Rappaport 		The American Journal of Medicine 2022
High viral loads: what drives fatal cases of COVID-19 in vaccinees? – an autopsy study
K Hirschbühl, T Schaller, B Märkl, R Claus, E Sipos, L Rentschler, A Maccagno, B Grosser, E Kling, M Neidig, T Kröncke, O Spring, G Braun, H Bösmüller, M Seidl, I Esposito, J Pablik, J Hilsenbeck, P Boor, M Beer, S Dintner, C Wylezich 		Modern Pathology 2022
Simulation applications to support teaching and research in epidemiological dynamics
W Getz, R Salter, L Vissat 		BMC medical education 2022
SARS-CoV-2 mRNA Vaccine Breakthrough Infections in Fully Vaccinated Healthcare Personnel: A Systematic Review
C Ledda, C Costantino, G Motta, R Cunsolo, P Stracquadanio, G Liberti, H Maltezou, V Rapisarda 		Tropical Medicine and Infectious Disease 2022
Assessment of SARS-CoV-2 vaccination status in SARS-COV-2 infected patients admitted in Dr Ruth K.M. Pfau, Civil Hospital Karachi.
Rasheed T, Ali FS, Zuberi BF, Sadaf R 		Pakistan Journal of Medical Sciences 2022
Severe acute respiratory syndrome coronavirus 2 vaccine breakthrough infections: A single metro-based testing network experience.
Strickler SS, Esper A, Wells L, Wood A, Frediani JK, Nehl E, Waggoner JJ, Rebolledo PA, Levy JM, Figueroa J, Ramachandra T, Lam W, Martin GS 		Frontiers in Medicine 2022
Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses
R Thiruvengadam, A Awasthi, G Medigeshi, S Bhattacharya, S Mani, S Sivasubbu, T Shrivastava, S Samal, DR Murugesan, BK Desiraju, P Kshetrapal, R Pandey, V Scaria, PK Malik, J Taneja, A Binayke, T Vohra, A Zaheer, D Rathore, NA Khan, H Shaman, S Ahmed, R Kumar, S Deshpande, C Subramani, N Wadhwa, N Gupta, AK Pandey, J Bhattacharya, A Agrawal, S Vrati, S Bhatnagar, PK Garg 		The Lancet Infectious Diseases 2021
In-depth Characterization of Vaccine Breakthrough Infections With SARS-CoV-2 Among Health Care Workers in a Dutch Academic Medical Center
L Rümke, F Groenveld, Y van Os, P Praest, A Tanja, D de Jong, J Symons, R Schuurman, T Reinders, L Hofstra, S Nierkens, S Thijsen, M Heron, R Lebbink, J Beekman, M Nijhuis, A Wensing 		Open Forum Infectious Diseases 2021

Advertisement